🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › Texas › Austin

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Austin, TX keessatti

Qorannoo 5 Diffuse Large B-Cell Lymphoma f Austin fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Texas Oncology - Central South, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06500273

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Namoota walitti qabaa jiraSadarkaa 2
  • Texas Oncology - Central/South Texas ( Site 8006), Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06890884

Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Natera, Inc., Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07750886

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • St. David's South Austin Medical Center, Austin
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology, Austin, TX 78758
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06451497

Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti

Qorannoo biroo Austin keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.